Tag: SoniVie
Boston Scientific to acquire renal denervation technology developer SoniVie
Boston Scientific has entered into a definitive agreement to acquire SoniVie Ltd, a privately he...
SoniVie receives FDA IDE approval for pilot study to treat hypertension with renal artery denervation TIVUS technology
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administration (FDA) granted inve...
